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Abstract
DIETARY COMPLIANCE IN RHEUMATOID ARTHRITIS PATIENTS
by
Dorine T. Lam, Edwin H. Krick, Irma B. Vhymeister,
Ella Hasso-Haddad, and David E. Abbey
Poor adherence to dietary instructions is a critical problem in
nutritional care. This study points out the level of adherence that can
be achieved over a relatively long period of time among chronically ill
outpatients and the usefulness of the 24-hour recall and a food frequency
questionnaire in assessing compliance.
Twenty two rheumatoid arthritis patients volunteered to enroll in
this pilot diet study, fifteen remained with the study for the stipulated
period of 18 months. The study consisted of three parts: an initial six-
month baseline period (Period I), a six-month experimental period (Period
II) in which the patients' diet was altered, and a final six-month
baseline period (Period III). The patients were scheduled for return
visits every two months.
The dietary plans were individualized to conform as closely as
possible to the subject's lifestyle and were designed to provide 13% of
the kilocalories as protein, 30% of the kilocalories as fat and be re­
stricted in added sugar to 24 grams (six teaspoons) per week. Both 24-
hour recalls and food frequency questionnaires were used here as assess­
ment tools.
Repeated measures analysis of variance test showed significant dif­
ferences in mean daily intakes of protein, fat and sugar between the three
periods. Similar results were obtained from both the 24-hour recalls and
the food frequency questionnaires. The modified least significant differ­
ence method of pairwise multiple comparison, showed that Period II is
different from Period I in all the nutrients analysized.
The correlation analysis to compare dietary intake data obtained by
24-hour recalls and the food frequency questionnaires at the initial.
month 8 and month 14 showed few statistically significant correlations
primarily because of small sample size.
The patients were instructed to return to their original diet during
Period III to minimize bias and the placebo effect and to maximize the
accuracy of the statistics. Although 80 percent of the patients failed
to reach complete dietary adherence but significant reduction in intake
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INTRODUCTION
Poor adherence to dietary instructions is a critical problem in
nutritional care. Since dietary modifications are of no value unless they
are applied, the need for improving compliance is obvious to dietitians
and nutritionists. Despite growing interest in the issue, relatively few
studies have given adequate consideration or provided insights to achiev­
ing dietary compliance among individuals with chronic conditions in the
usual outpatient care setting.
This report describes a preliminary study designed to evaluate the
impact of a low protein, low fat, restricted sugar dietary regimen on
selected clinical criteria in persons with rheumatoid arthritis. The
clinical results of the study will be published elsewhere. However, in
order to successfully evaluate the effectiveness of the dietary manipu­
lations, it was imperative to assess patient compliance. The purpose of
this paper is to determine the level of adherence that can be achieved
over a relatively long period of time among outpatients and to evaluate




Diet and Rheumatoid Arthritis
The relationship of diet to rheumatoid arhtritis has been the sub­
ject of much speculation and controlled clinical trials have been scanty.
In an extensive review of literature, Robinson (1) concluded that no
specific nutritional abnormality has been documented in rheumatoid arthr­
itis. However, it is known that immunologic reactions appear to play a
major role in the perpetuation of the inflammation (2-5). A number of
restrictions can alter the bodyTs immunologic systems and possibly delay
the onset of inflamination in autoimmune disease (6-10). There have also
been reported associations between elevation of serum lipids and the oc­
curence of rheumatic complaints (11). In addition, it has been popular to
regard fasting as beneficial to patients with rheumatic disease. In a
recent study by Skoldstam et.al. (12), sixteen randomly selected patients
with classical rheumatoid arthritis underwent 7-10 days of fasting, fol­
lowed by a 9-week period on a lactovegetarian diet. After being on the
lactovegetarian diet for three weeks, the temporary improvement as a re­
sult of fasting began to wear off and at the conclusion of the study the
patients showed no change in pain, stiffness or consumption of analgesics
compared to the pre-study period. The reason for the lessening of symptoms
on a fasting regime is not known but consideration could be given to the
fact that caloric restriction leads to adaptations in many endocrinological
responses which could affect inflammation and autoimmune reactions. Since
the effects of fasting are of dubious significance when one considers the
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chronic nature of rheumatoid arthritis, it seemed worthwhile to examine
the effects of dietary protein, fat and sugar restriction on arthritic
symptoms.
Dietary Compliance
Facilitating adherence to dietary instructions is a key issue in the
management of diet related chronic conditions. In a recent review, Glanz
(13) concluded that noncompliance with dietary regimens is at least as
frequent as noncompliance with medical regimens. There were wide differ­
ence in compliance rates reported even among similar dietary trials. Often
this variation was due to differences in the criteria utilized to assess
compliance which makes comparisons among studies meaningless (13).
Attempts to identify patient characteristics or demographic features
that may be predictive of adherence have not been successful. In general,
parameters such as age, sex, marital status, education, social class, and
current activity were not related to compliance (14-18). Studies have
indicated that the severity of the illness may increase cooperation (19),
whereas, longer duration of treatment is associated with greater noncom­
pliance (20) .
Stunkard (21) suggests that adherence is a function of the social
context in which the patient is managed with the regimen, provider and
patient-himself, all influencing the extent of adherence. The most impor­
tant aspect of the regimen is its complexity which relates directly
to poor adherence (22). Although the mastery of factual information about 
the illness and its treatment have not been associated with compliance (23),
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patients must have a good understanding of how to reach the final goal
(24).
The quality and consistency of the provider-patient interactions
has a positive impact on subsequent behavior. "Whether patients have a
relationship with one (25) or several professionals (26) is not as impor­
tant as the interaction process itself. Patterns of communications cha­
racterized by sensitivity, lack of tension and adequate feedback resulted
in a higher level of patient compliance with instructions (17,18,27,28).
Dietitians with competency in counseling skills and an orientation to
social influences had a greater impact on their patients’ subsequent be­
haviors (14). Adequate interaction requires that the patient's expecta­
tions from their provider have been met (28).
Stimson (29) and Hayes-Bautista (30) propose that insights to com­
pliance can best be obtained by analyzing the patient's own perceptions
and explanations of his or her behavior. They point out that patients
will follow those instructions they consider to be appropriate for them.
Approaching the problem from the patient's perspective has also been em­
phasized in the theoretical models derived from social psychology that
have been applied to the study of dietary adherence, such as behavioral
analysis and the Health Belief Model. Behavioral analysis focuses on the
extent by which antecedents and consequences of a specific behavior in­
fluence changes in that behavior (31). The Health Belief Model (17,32,33)
postulates that an individual's likelihood of compliance with a prescribed
regimen is a function of that person's health motivation, perceived sus-
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ceptibility to illness, perceived severity of consequences of the illness
and the belief that the efficacy of the treatment regimen outweigh the 
barriers involved in following the regimen.
Assessing Dietary Compliance
In order to draw valid conclusions from dietary studies, it is im­
perative to assess adherence correctly. Although indirect methods such
as biochemical determinations of blood and urinary levels of nutrients or
metabolites and anthropometric measurements (34) have been applied to
adherence research, dietary intake data based on patient interviews is
the most widely utilized tool (35,36). The task involves determining
what the subject eats and how closely this approximates the dietary re­
commendations. Mojonnier (37) has pointed out that methods used to mea­
sure food intake of individuals should be feasible, valid and represen­
tative of habitual intake. Feasibility demands that information on food
intake be based on self-reports rather than observation. Although a num­
ber of comparative studies have attempted to ascertain the validity of
the various dietary interview methods, there exists a lack of agreement
on the best method to use (37-51).
Since no single method is accepted as valid or reliable for estima­
ting the dietary intake of "free-living" individuals, it is necessary to
use more than one method (49-51). The 24-hour recall and food frequency
questionnaires are simple and practical tools to use in a clinical set­
ting. Studies have shown that both appear to be relatively accurate in
reflecting recent food intake (40-44,46). Their major limitation is their
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failure to reflect habitual food intake (49,50). This limitation may be 
circumvented by repeated interviews and recalls (50,51).
METHODS
Subject Selection
Subjects for the study were recruited from among patients frequenting
a rheumatoid arthritis clinic. Participation in the experiment was volun­
tary and of the 22 subjects enrolled, fifteen remained with the study for
the stipulated period of 18 months. Eligibility for inclusion in the
study required that individuals be adults, meet the criteria for diagno­
sis and classification of rheumatic diseases Functional Class Level II
(functional capacity adequate to conduct normal activities despite handi­
cap of discomfort or limited mobility of one or more joints) and Level III
(functional capacity adequate to perform only few or none of the duties
of usual occupation or self care), and be stable on gold, penicillamine,
or nonsteroidal anti-inflammatory drugs for the three months prior to
initiation of the study. Excluded from the study were those with concur­
rent disease conditions such as hypertension, renal disease or diabetes.
Study Protocol
The study consisted of three parts: an initial six-month baseline
period (Period I), a six-month experimental period (Period II), in which
the patients’ diet was modified, and a final six-month period similar to
the baseline. Table 1 outlines the overall study protocol showing the
sequence of bi-monthly clinic visits, dietary intake assessments and other
parameters included in the study. Baseline data on dietary intake, physi­
cal performance and laboratory values were established during the initial
six-month period. Since subjects were used as their own controls, it was
7
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necessary to minimize the placebo effect by including a final six-month
baseline period during which subjects were to return to their original diets.
The dietary modification period began six months after subjects were
first enrolled in the study at which time they were carefully and tho­
roughly instructed in the experimental diet by the research dietitian.
Dietary plans were individualized to conform as closely as possible to
the subject's lifestyle and were designed to provide 13% of the kilocalo­
ries as protein, 30% of the kilocalories as fat and be restricted in
added sugar to 24 grams (six teaspoons) per week. The intensive instruc­
tion coupled with the support of the medical personnel assured that each
patient understood his diet. The subject's energy requirement was calcu­
lated based on the Harris-Benedict Equation and an allowance for physical
activity was added to provide sufficient kilocalories to maintain weight.
The dietary plans were based on the food exchange lists of calorie
controlled diabetic diets (52) and low protein renal diets (53). These
consisted of six exchange lists: bread, protein, fruits, vegetables, milk
and fats. No commercially formulated low protein products were recommended
and fruit and fruit juices were allowed freely to supplement the total
caloric intake required to maintain weight.
Evaluation of baseline and experimental dietary intake was accom­
plished through interviews conducted by the research dietitian trained in
interviewing techniques. Two methods—the 24-hour recall and a food
frequency questionnaire were used to evaluate intake. A standard protocol
and probing procedure was followed for the 24-hour recalls during which
9
subjects were asked to state the amounts of food and beverages they had
consumed during the previous 24-hour period. To better reflect usual in­
take, the 24-hour recall was repeated every two months and intakes from
the recalls were averaged within the different study periods. A total
of four 24-hour recalls were averaged for Period I and three each for
Periods II and III.
In addition to the 24-hour recall, the dietitian administered a
food frequency questionnaire at the initial, month 8 and month 14 visits.
This questionnaire was designed to cross examine and validate the 24-hour
recalls and consisted of a list of 81 foods of specified portion sizes.
The respondents were asked to indicate the number of times per day, or
per week he or she ate the food.
Quantitative estimates of energy content and grams of protein, fat and 
added sugar were obtained from food composition tables (54-56) for each
food item reported in the 24-hour recalls. The values were tabulated and
a mean calculated for each subject in Periods I, II, and III. A compu­
terized program was available to assist in the tabulation of results
from the food frequency questionnaire. The data collected from the food
frequency questionnaire was compared with the means obtained from the
24-hour recalls.
Assessment of Compliance
In order to derive an accurate estimate of compliance for each sub­
ject, values from the 24-hour recalls and food frequency questionnaire
were compared to the amounts specified in the individualized dietary
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plans in which the subject was instructed. The criteria established for
the experiment defined caloric compliance as achieving within 100 kilo­
calories, protein and fat compliance as achieving within five grams and
sugar compliance as achieving less than three grams per day of the level
instructed.
At the completion of the study, the participants were asked to
state whether they considered themselves to have followed the experimen­
tal diet or some modification of it and whether they would continue to
do so in the future. They were also requested to state their underlying
motivation for continuing to follow the diet.
Statistical Analysis
Repeated Measures Analysis of Variance Test were used to determine
whether there were significant differences in the mean intake of energy.
protein, fat and added sugar between the three periods as assessed by
24-hour recalls. The Modified Least Significance Difference Method (57)
for pairwise multiple comparison was used to determine which time period
differ significantly from each other. Correlation Coefficient were com­
puted to test the level of association between the nutrient intake as
measured by the 24-hour recalls versus the food frequency questionnaires.
RESULTS MD DISCUSSION
Fifteen subjects of an initial twenty-two completed the entire 18-
month period required by the study. Table 2 lists the patients’ reasons
for discontinuation from the study. Only half of the dropouts were re­
lated to the experimental diet. The dropouts were excluded from further
evaluation and analysis.
Table 3 shows mean daily intakes of energy, protein, fat and sugar
as determined by 24-hour recalls for periods one, two and three. The
question submitted to analysis was whether subjects did substantially
reduce (Period II) and increase (Period III) their intake of protein, fat
and sugar as instructed. Repeated measures analysis of variance test
using the means of the 24-hour recalls within each time period showed
significant differences (p<0.05) in mean daily intakes of protein, fat
and sugar between the three periods. Similar results were obtained when
the means from the food frequency questionnaires were used. Energy intakes.
which were tried to keep constant, did not differ significantly between
the three periods. Table 3 also indicates which time period differed
significantly from each other using the modified least significant dif­
ference method of pairwise multiple comparison. It is shown that Period
II is different from Period I in all the nutrients analysized. This indi­
cates that all the 15 patients were able to modify their diet in some
way. However, when asked to return to their original baseline diet, the
patients were able to go back to their original level of fats and added
sugar only. A possible explanation may be that fats and highly sweetened
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foods are cheaper than the protein foods, therefore more economical to
incorporate into the diet again.
A two-fold difference was found in sugar intake between the 24-hour
recalls and the food frequency questionnaire. A possible explanation for
this variation may be the fact that the 24-hour recall reflects what was
eaten the previous day which may not have included a sweetened item.
whereas, the food frequency questionnaire reflects total consumption for
one week which may have included one or more items with added sugar.
The number of subjects who achieved the regimen-specific criteria of
the experimental protocol are presented in Table 4. Although all 15 sub­
jects experienced a change in their diet, only two of them actually a-
chieved the goal of consuming within five grams of protein and fat and
less than three grams of sugar per day as specified by their individual­
ized dietary prescription and assessed by 24-hour recalls. The prescribed
low levels of protein and fat represented a major alteration in the
dietary habits of the subjects. As shown in Table 3, participants signi­
ficantly reduced their intakes of protein, fat and sugar, however, these
reductions rarely achieved the targeted levels, but tended to fall be­
tween the experimental diet and the subject’s baseline intake. Subjects
found it easier to avoid sweetened foods than to limit their intake of
protein and fat. One possible explanation may be related to the commonly
held belief that a high sugar intake is detrimental to health and this
was an opportunity to limit sweets.
An examination of Table 4 shows that a larger number of individuals
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seem to be compliant when evaluated by 24-hour recalls than when evaluated
by the food frequency questionnaire. This finding is consistent with
the observation made by Glanz (13) in reviewing dietary compliance stu­
dies that adherence rates vary with the scoring system employed to test
adherence. Compliance rates obtained in this study cannot be compared to
others reported in the literature because of the regimen specific crite­
ria and the scoring procedures which were applied.
Since no single adherence tool is universally considered to be valid.
the results emphasize the necessity of utilizing multiple tools to mea­
sure adherence. For research purposes, the food frequency questionnaire
serves as a reliability check on the 24-hour recalls. However, the impor­
tance of multiple tools is most pertinent to the clinical setting where
the primary function of dietary evaluation is to arouse the awareness of
patients regarding their dietary patterns. Dietary assessment may serve
as a teaching tool to help translate dietary modifications to practice
and can provide positive reinforcement and feedback to improve compliance.
Such insights can only be obtained if the diet is examined within a
framework of actual recall as well as usual patterns of intake.
The results of correlation analysis to compare dietary intake data
obtained by using the means of the nearest two 24-hour recalls and the
food frequency questionnaire at the initial, month 8 and month 14 visit
are presented in Table 5. A number of statistically significant correla­
tions (p< 0.05) were observed but because of the small sample size, these
should be interpreted with caution. It is interesting to note that pro-
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tein and sugar intake have marked shifts in the degree of correlation
coefficient across the time period with protein having a lower correla­
tion coefficient and sugar a higher correlation coefficient during the
experimental period. This would tend to underscore the importance of hav­
ing both measurements for the safe validation, although some of the fluc­
tuation may be due to the small sample size. Gam et.al. (49) stated that
the 24-hour recall may be used with confidence only if the sample size is
large. With small sample sizes, investigators have recommended performing
multiple recalls on each subject to improve the validity of the data
(50,51) as was done in this study. Table 3, where mean intakes obtained
by multiple 24-hour recalls were used, showed a high level of concurrence
with food frequency data in reflecting dietary changes.
To minimize bias and the placebo effect and to maximize the accuracy
of the statistics, a reversal design was used for this experiment. The
experimental protocol dictated that subjects return to their baseline
diets during the third period. Invariably they failed to do so as indi­
cated in Table 3. This reluctance to return to habitual intake despite
the encouragement of a highly supportive clinical staff suggests certain
dynamics which were not anticipated when the study was first designed.
When queried about their intention to adhere to the restricted diet or
some modification of it beyond the experimental period, nine of the fif­
teen subjects indicated that they would continue to follow the restricted
diet. The reasons they gave could be summarized by one typical statement: 
"I felt better on the diet". These results suggest an outcome—perceived
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benefit, that may be an important determinant of compliance.
Although research has not supported the value of diet in the treat­
ment of rheumatoid arthritis, studies have shown that patients consider
diet to be of great importance (11-12). Rheumatoid arthritis differs
from asymptomatic chronic conditions because of the constant presence of
pain. If the experimental diet had not resulted in some perceived bene­
fit, it would have been quickly discarded by the patients. Although most
were unable to conform fully to the recommendations, they seemed hesitant
to disregard the restrictions. Behavioral analysis and the Health Belief
Model postulate that favorable outcomes and perceived benefits influence
the extent of adherence (31-33). The patient must believe that the regi­
men prescribed will, in fact, reduce the severity of his or her condition
(24). Although the various correlates of the above hypotheses were not
tested in this study, the results suggest that many individuals did in­
deed perceive a high degree of relative advantage, which was evidenced
by their reluctance to return completely to their original diets and by
their willingness to continue the diet in the future.
SUMMARY
Twenty two rheumatoid arthritis patients were entered in this pilot
diet study. Fifteen remained in the diet until the end of the 18 month
study period. These patients were instructed in the usual outpatient
care setting on a diet consisting 13% of total calories as protein, 30%
of total calories as fat and restricted in added sugar to 24 grams (six
teaspoons) per week. Although less than 15 per cent of the patients
achieved the target reduction of protein, fat and sugar, all the patients
showed a significant reduction in these constituents as compared to
their original diet. It can be stated confidently hereby, a good com­
pliance rate can be expected in patients in an outpatient clinic if there
is a highly supportive staff and frequent follow up visits are scheduled.
A correlation study of the 24-hour recalls and the food frequency
questionnaires showed 44 per cent of the correlations being significant
because of the small smaple size and the measurement differences between
the two assessing tools. Therefore it is necessary to utilize both the
24-hour recalls and the food frequency questionnaires for a more accurate
data collection. It is also noted that a reversion diet should not be
recommended in the future, because the patients perceived an improvement
in their physical condition during the restricted dietary period and re­
fused to return fully to their original diet.
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X XX XX X X XXX
walking time xx x xx XX XX X
grip strength x xx x x xx xx x
Westergren sed. rate x x x xx X X XXX
weight x xx x x x x xx x
other laboratory datas x xxx
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Table 2. Reasons patients dropped out of the study-
numb er percent reasons
4 50 did not like the diet
2 25 recurrence of active arthritis
1 12.5 moved away
1 12.5 existence of other medical 
problems
8 100 total













24-hr recall 24-hr recall 24-hr recall




70.34+22.39 50.55+12.83 59.06+19.46 0.001 II III I




32.15+16.55 13.40+17.05 32.02+19.69 0.0005 II I III
percentage of kilocalories: 
protein 14.91+2.55 15.11+2.3316.79+2.77 0.04 II III I
fat 37.64+6.15 32.72+7.22 35.14+7.19 0.005 II III I
3.76+4.13 7.93+4.587.16+3.65 0.001 II I IIIsugar
* N=15 ‘ :
-f Mean standard deviation
Repeated measures analysis of variance test, significant value, p<0.05 
Modified least significant difference method of pairwise multiple comparison:
long line underneath the periods = there is no difference between the two periods 






Table 4. Number of patients who achieved the target instructed 
levels of protein, fat, and sugar during the second 
period*




protein (within five grams 
of level instructed)
3367 510
27fat (within five grams of 
level instructed)
43 20
sugar (any amount below 
three grams of sugar)
4780 712
6.7total calories (within 
100 kcal. of level 
instructed)
1335
1 6.713protein, fat, and sugar 2
* N = 15
t Food frequency questionnaire
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Table 5. Correlation of dietary intake obtained by repeated 
24-hour recalls and food frequency questionnaires*
nutrients as 
percent kilocalories





* N = 15
+ Correlation coefficient 
Significant at 0.05 level 
Significant at 0.01 level1
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Table 6. Number of patients that would continue to follow the low protein, 
fat and sugar diet after the 18 months study period
patients’ future diet plannumber percent
5 33 followed the diet; would continue to follow 
the restrictive diet as prescribed
4 27 followed the diet; would follow a less 
restrictive diet in the future
3 20 followed the diet; would not continue to do
so
didn’t follow the diet; would not follow the 
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RHEUMATOID ARTHRITIS NUTRITION QUESTIONNAIRE
INSTRUCTIONS: The following items are classified on a DAILY or WEEKLY basis. For some 
you should check the number of times an item is used while for others you should check 
the number of servings or amounts used. Answer each question according to your current 
usual or average usage. If you eat some of these foods only rarely or occasionally, 
mark the "less than 1" category.
PLEASE ANSWER EACH QUESTION
DAILY BASIS (1-20)
1. Whole milk, whole milk plain yogurt,
chocolate milk
TOTAL CUPS PER DAY
x( ) None 
2( ) Less than 1 
3( ) 1-2 
-( ) 3-4 
5( ) Over 4
2. Low fat milk (2%), low fat plain
yogurt.
TOTAL CUPS PER DAY
1{ ) None 
2( ) Less than 1 
3( ) 1-2 
4( ) 3-4 
s( ) Over 4
3. Non-fat milk, skim milk, buttermilk.
TOTAL CUPS PER DAY
3( ) None 
2( ) Less than 1 
3( ) 1-2 
4( ) 3-4 
5( ) Over 4
4. What ONE type of bread do you use most 
of the time? (check only one).
1( )100% Whole wheat or whole grain 
2( )Sprouted wheat or wheatberry 
3( jother (rye, cracked wheat, soy,
4( )White (enriched or unenriched)
5. Please indicate TOTAL NUMBER OF SLICES 
PER DAY of all types of bread.
3( ) None 
2( ) Less than 1 
3( ) 1-3 
-( ) 4-5 
5( ) Over 5
6. Fresh fruits (apple, pear, orange, 
bananas, etc.)
TOTAL SERVINGS PER DAY
x( ) None 
2( ) Less than 1 
3( ) 1-2 
4( ) 3-4 
5( ) Over 4
7. Sweetened fruit juices (fresh, frozen 
or canned) 1 cup = 8 oz.
TOTAL CUPS PER DAY
*( ) None 
2( ) Less than 1 
3( ) 1-2 
4( ) 3-4 
5( ) Over 4
116
127
Unsv/eetened fruit juices (fresh, frozen 
or canned) 1 cup = 8 oz.
TOTAL CUPS PER DAY
) None
2( ) Less than 1 
3( ) 1-2 
4( ) 3-4 




9. Fruit drinks (not fruit juice, et. 
High C, Tang, grape drink, etc.)9
TOTAL CUPS PER DAY
l( ) None 
2( ) Less than 1
H ) 1-2
4( ) 3-4 
5( ) Over 4
10. Tubers (potatoes, yams, sweet potatoes, 
taro, etc.)
TOTAL SERVINGS PER DAY
!( ) None 
2( ) Less than 1
Over 2





Please go to the top of the next column.
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Vegetables (peas, corn, green beans, 
broccoli, etc.) % cup =1 serving.
TOTAL SERVINGS PER DAY
*( ) None 
2( ) Less than 1 
43( ) 1-2 
( ) 3-4 
5( ) Over 4
12. Salt in cooking
TOTAL TEASPOONS PER DAY
*( ) None 
2( ) Less than 1 
3( ) 1-2 
4( ) 3-4 
5( ) Over 4
13. Salt at the table 
TOTAL SHAKES PER DAY
) None
) Less than 1 
3( ) 1-2 
-(- ) 3-4 
5( ) Over 4
14. Diet soft drinks (sugar free)
TOTAL 8 oz. GLASS PER DAY
11. 17. Oil used in cooking.
TOTAL NUMBER OF TEASPOONS PER DAY 
( ) None
2( ) Less than 1 
3( ) 1-2 
4( ) 3-5 
5( ) Over 5
i2216
18. Butter
. TOTAL TIMES PER DAY 
) None
2( ) Less than 1 
3( ) 1-2 
4( ) 3-5 
5( ) Over 5
23 i
17
19. Margarine or soft margarine 
TOTAL TIMES PER DAY
;is24 NoneLess than 118
3( ) 1-2 
4( ) 3-5 
5( ) Over 5
20. Mayonnaise and sandwich spread.
TOTAL TABLESPOONS PER DAY
1[ ) None 
2( ) Less than 1 
3( ) 1-2 
4( ) 3-5 




3( ) 1-2 
4( ) 3-5 
5( ) Over 5
15. Beverages soft drinks (cola 
beverages, 7-up, root-beer, 
carbonated drinks, punch, lemonade, 
etc.)
TOTAL 12 oz. GLASS PER DAY 
None
Less than 1
21. Jams, jellies, molasses, & syrups 
TOTAL TEASPOONS PER DAY 
) None
) Less than 1
3( ) 1-3
M ) 4-7
5( ) Over 7
Sugar and honey (added to coffee, 
tea, cereal, etc.}
TOTAL TEASPOONS PER DAY
J( ) None
2( ) Less than 1
3( ) 1-2
4( ) 3-5




4( ) 3-5 
5( ) Over 5 22.
16. What kind of oil do you use in your 
cooking usually? (check only one)
Lard
Shortening (Crisco, etc.)
3( ) Vegetable Oil (Wesson, etc.) 
k( ) Peanut Oil 
5( ) Safflower Oil 
6( ) Corn Oil 
7( ) Soy Oil
®( ) Olive Oil 
9( ) Cottonseed Oil
Please go to the top of the next column. |
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28. Dried fruits (raisins, dates, 
apricots, prunes, etc.)
TOTAL SERVINGS PER WEEK
) None
) Less than 1
3( ) 1-3
4( ) 4-7
5( ) Over 7
29. Plain green salad and relishes 
(tossed green, carrot sticks, 
celery sticks, radishes, tomatoes, 
cucumber, etc.)
TOTAL SERVINGS PER WEEK
x( ) None
2( ) Less than 1
3( ) 1-2
4( ) 3-4
5( ) Over 4
30. Salads with mayonnaise (cole slaw, 
carrot raisin, potato salad, 
macaroni salad, etc.) h cup = 1 servinc
TOTAL SERVINGS PER WEEK
( ) None 
2( ) Less than 1 
3( ) 1-2 
) 3-4
5( ) Over 4
31. Salty foods (chips, fries, olives, 
fish canned in brine, pickles, sauer­
kraut, crackers, etc.)
TOTAL TIMES PER WEEK
3( ) None 
2( ) Less than 1 
3( ) 1-3 
4( ) 4:7 
5( ) Over 7
32. Commercial canned soup 
TOTAL TIMES PER WEEK
) None
) Less than 1 
3( ) 1-2 
4( ) 3-4 
5( ) Over 4
33. How frequently do you eat flesh foods? 
(fish, fowl, meat, pork).
J( ) Never - Please skip to 48.
2( ) Less than Weekly )
3( ) Weekly 
4( ) Daily
Please turn to back of page.
23. Other non-sugar sweeteners
(Please specify) ________
TOTAL TEASPOONS PER DAY
1{ ) None 
2( ) Less than 1 
3( ) 1-2:i) ”




Refined pasta (refined white: 
spaghetti, macaroni, noodle, j
lasagna, etc.)
TOTAL TIMES PER WEEK
( ) None
2( ) Less than 1
3( ) 1-2 !
4( ) 3-5 I
5( ) Over 5
25. Unrefined pasta (whole wheat: 
spaghetti, noodle, macaroni, 
lasagna, etc.)
TOTAL TIMES PER WEEK
( ) None
2( ) Less than 1
3( ) 1-2
4( ) 3-5 i
5( ) Over 5
26. Canned/frozen fruit (packed in 
heavy or light syrup)
h cup = 1 serving
TOTAL SERVINGS PER WEEK
( ) None 
2( ) Less than 1 
3( ) 1-2 
4( ) 3-4 
5( ) Over 4
27. Canned/frozen fruit (packed in water)
h cup = 1 serving
TOTAL SERVINGS PER WEEK 
( ) None
2( ) Less than 1 















Please go to the top of the next column.
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Prepared meats (luncheon meat, sausage, 
corned beef, bacon, ham, etc.)
TOTAL TIMES PER WEEK
1( ) None 
2( ) Less than 1
H ) 1-2
4( ) 3-5 
5( ) Over 5
41. • AVERAGE SERVING SIZE IN OUNCES.
*( ) Less than 1 oz. (2 slices bacon,
sausage link or 2V sausage pattie.) 
2( ) 1-2 oz. [% slice ham, slice luncheon 
meat, frankfurter)
3( ) 3-4 oz. (knockwurst or polish sausage 
4" sausage pattie).
4( ) Over 4 oz.
42. Poultry (chicken or turkey)
TOTAL TIMES PER WEEK
34. Beef, veal or lamb (LEAN-with all 
fat trimmed off).
TOTAL TIMES PER WEEK
*( ) None 
2( ) Less than 1 
?( ) 1-2 
) 3-5
5( ) Over 5
35. AVERAGE SERVING SIZE IN OUNCES
3( ) Less than 1 oz. (1" beef cube)
2( ) 1-2 oz. (meatballs, lean frank­
furter, % slice roast, veal 
cutlet)
3( ) 3-4 oz. (Lean hamburger pattie,
Y' slice meat loaf, small steak) 
M ) Over 4 oz. (full size steak)
36. Beef and lamb (high fat-no fat 
trimmed off)
TOTAL TIMES PER WEEK
) None
) Less than 1 
3( ) 1-2 
4( ) 3-5 
s( ) Over 5
37. AVERAGE SERVING SIZE IN OUNCES
x( ) Less than 1 oz. (1" beef cube)
2( ) 1-2 oz. (meatballs, frankfurter, 
h slice roast)
3( ) 3-4 oz. (hamburger pattie,
V' slice meat loaf, small steak) 






3( ) 1-2 
4( ) 3-5 
5( ) Over 5
43. AVERAGE SERVING SIZE IN OUNCES.
48 x( ) Less than 1 oz (V chicken slice)
2( ) 1-2 oz. (drumstick, thigh, wing,
V turkey slice)
3( ) 3-4 oz. (% breast of chicken, 2 wings, 
2 thighs, 2 drumsticks).
4( ) Over 4 oz. (breast of chicken, cornish 
hen).
44. Fish (other than shellfish)
TOTAL TIMES PER WEEK
49 x( ) None
2( ) Less than 1 
3( ) 1-2 
4( ) 3-5 
5( ) Over 5
45. AVERAGE SERVING SIZE IN OUNCES
50 !( ) Less than 1 oz. (bite-size fish cake,
sardine.).
2( ) 1-2 oz. (fish stick, tuna sandwich)
3( ) 3-4 oz (y fillet)
4( ) Over 4 oz. (1" fillet or steak)
42
38. Pork




3( ) 1-2 
4( ) 3-5 
s( ) Over 5
39. AVERAGE SERVING SIZE IN OUNCES
x( ) Less than 1 oz. (2 slices bacon, 
sausage link or 2y sausage 
pattie)
2( ) 1-2 oz. {h slice ham, pork chops, 
slice luncheon meat, frankfurter) 
3( ) 3-4 oz. (knockwurst or polish 
sausage, 4" sausage pattie)
4( ) Over 4 oz.
44
Please turn to the next page.Please go to the top of the next column.
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Dried or canned beans, lentils, 
split pea, pinto beans, lima beans, 
kidney beans, garbanzo beans, etc.
TOTAL TIMES PER WEEK
*( ) None
2( ) Less than 1
?( ) 1-2
4S( ) 3-5
s( ) Over 5
46. Shellfish, organ meats
TOTAL TIMES PER WEEK
1[ ) None 
2( ) Less than 1 
3( ) 1-2 
“( ) 3-5 
5( ) Over 5
47. AVERAGE SERVING SIZE IN OUNCES.
( ) Less than 1 oz (1 oyster,
1 clam, 5 medium shrimp)
2( ) 1-2 oz. (V liver slice, V kidney 
slice)
3( ) 3-4 oz. (1 serving crab meat, H pair 
sweetbreads, 1 serving brains)
4( ) Over 4 oz (1 lobster in shell)
48. Homemade vegetarian entrees (made
from nuts, seeds, cheese, eggs).
TOTAL TIMES PER WEEK
1[ ) None 
2( ) Less than 1 
3( ) 1-2 
4( ) 3-5 
5( ) Over 5
49. Commercial vegetarian soy protein 
(fried chicken, stripples, chicketts, 
tuno, luncheon slices, etc.)
TOTAL TIMES PER WEEK
1( ) None 
2( ) Less than 1 
3( ) 1-2 
4( ) 3-5 
s( ) Over 5
50. Commercial vegetarian gluten protein 
(dinner cut, scallops, vegeburgers, 
choplets.)
TOTAL TIMES PER WEEK
3( ) None 
2( ) Less than 1 
3( ) 1-2 
4( ) 3-5 
5( ) Over 5
51. Commercial vegetarian nutmeat protein 
products (numete, nuteena, proteena, etc.)
TOTAL TIMES PER WEEK
1{ ) None 
2( ) Less than 1 
3( ) 1-2
-( ) 3-5 
5( ) Over 5





53. AVERAGE SERVING SIZE IN CUPS
:( ) cup or less 
2( ) 1 cup 
3( ) 1% cup 
4( ) 2 cups or more
54. Nuts and seeds (peanut,, almond, 
cashew, sunflower, tahini, etc.)
TOTAL TIMES PER WEEK
) None
) Less than 1 
3( ) 1-3 
4( ) 4-7 
s( ) Over 7
55. AVERAGE SERVING SIZE IN TABLESPOONS
( ) Less than 1 tbsp.
2( ) 1-2 tbsp.
3( ) 3-5 tbsp.
4( ) Over 5 tbsp.
56. Nut butters (peanut, almond, cashew, 
sunflower, etc.)
TOTAL TIMES PER WEEK
J( ) None 
2( ) Less than 1 
3( ) 1-3 
\ ) 4-7 







57 AVERAGE SERVING SIZE IN TABLESPOONS
x( ) Less than 1 tbsp.
2( ) 1-2 tbsp.
3( ) 3-5 tbsp.
4( ) Over 5 tbsp.
55
62
Cheese (cheddar, swiss, cottage, edam, 
ricotta, mozzarella, longhorn, etc.)
1 oz. = 1 serving
TOTAL TIMES PER WEEK 
( ) None 
2( ) Less than 1 
3( ) 1-3 
-( ) 4-7 
s( ) Over 7





Eggs (include those used in recipes) 
TOTAL TIMES PER WEEK 
) None
) Less than 1 
3( ) 1-3 
4( ) 4-7 
5( ) Over 7
59. 65. Doughnuts
TOTAL TIMES PER WEEK 
( ) None
2( ) Less than 1 
3( ) 1-3 
4( ) 4-7 
s( ) Over 7
Puddings
TOTAL TIMES PER WEEK
M ) None 
2( ) Less than 1 
3( ) 1-3 
4( ) 4-7 
5( ) Over 7
Jello
TOTAL TIMES PER WEEK 
) None
) Less than 1 
3( ) 1-3 
4( ) 4-7 
5( ) Over 7
Other Sweet Desserts (Please specify)
64 70 1
60. Cake 66.
TOTAL TIMES PER WEEK 
) None
) Less than 1 
3( ) 1-3 
4( ) 4-7 
5( ) Over 7
65 71
61. Pie 67.
TOTAL TIMES PER WEEK 
) None
) Less than 1 
3( ) 1-3 
4( ) 4-7 
5( ) Over 7
66 72
62. Ice Cream




67 TOTAL TIMES PER WEEK
73 3( I NoneLess than 1•11
5( ) Over 7\
Cookies
2(
3( ) 1-3 
4( ) 4-7 
5( ) Over 763. 74 75
TOTAL TIMES PER WEEK
*( ) None 
2( ) Less than 1 
3( 1-3
-( ) 4-7 
5( ) Over 7
69. Wine





> 1"2 4( ) 3-5 
5( ) 6-10 
6( ) Over 10
64. Sweet Rolls
TOTAL TIMES PER WEEK
l[ ) None 
2( ) Less than 1 
3( ) 1-3 
4( ) 4-7 
5( ) Over 7
70. Beer
TOTAL 12 oz. CAN/BOTTLE PER WEEK
3( ) None 
2( ) Less than 1 
3( ) 1-2 
4( ) 3-5 
5( ) 6-10 
6( ) Over 10
69
77
Please go to the top of the next column. Please turn to the next page.
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Hard Liquor (whiskey, bourbon, rum, 
etc. including the amount of liquor 
in cocktails that you drink).
TOTAL SHOT/DRINKS PER WEEK
) None
) Less than 1 
3 ( ) 1-2 
) 3-5 
s( ) 6-10 
6( ) Over 10
71. 77. Please indicate which of the follcning 
salad dressings you use most often:
M ) Commercial regular mayonnaise-type
2( ) Commercial regular oil-type
3( ) Commercial lowfat-type
78. Salad Dressing
TOTAL NUMBER TABLESPOONS PER WEEK
J( ) None
2( ) Less than 1
3( ) 1-3
"( ) 4-7
5( ) Over 7
79. Fried foods (potato chips, french -ries, 
hash browns, fried meat, fried poultry, 
fried fish, fried eggs, etc.)
TOTAL TIMES PER WEEK
1( ) None
2( ) Less than 1
3( ) 1-3
4( ) 4-7
5( ) Over 7
80. Avocado (1)
TOTAL TIMES PER WEEK
J( ) None
2( ) Less than 1
3( ) 1-3
4( ) 3-5
5( ) Over 5
81. Olives (10)
TOTAL TIMES PER WEEK
!( ) None
2( ) Less than 1
3( ) 1-3
“( ) 3-5





72. Flavored or frozen yogurt.
TOTAL TIMES PER WEEK 
3( ) None
2( ) Less than 1
3( ) 1-2
4( ) 3-4
5( ) Over 4
Refined cereals (corn flakes, malt-o- 
meal, cream of wheat, white rice, etc(
TOTAL TIMES PER WEEK
1(>) None 
2( ) Less than 1
3( ) 1-2
4( ) 3-5




1 4Whole grain cereals (cracked wheat, 
millet, cornmeal, brown rice, 
barley, oatmeal, etc.) '
74.
J( ) None 
2( ) Less than 1 
3( ) 1-2 
( ) 3-5 




TOTAL CANDIES PER WEEK
1[ ) None 
2( ) Less than 1 
3( ) 1-3 
4( ) 4-7 
5( ) Over 7
•9
How often do you take the indicated amount of 
the following diet supplements?
Multiple vitamin pills:
1 pill per dose
TOTAL TIMES
:( ) Rarely or Never 
2( ) 1-2 a week 
3( ) 3-6 a week 
4( )•Daily or more often
82.
Creamed products (whipped cream, sour 
cream, half & half, evaporated milk, 
etc.)
TOTAL TIMES PER WEEK
l( ) None 
2( ) Less than 1 
3( ) 1-3 
4( ) 4-7 









1( ) Rarely or Never 
2( ) 1-2 a week 
3( ) 3-6 times a week 
4( ) Daily or more often
Vitamin C Pills: Less than 100 mg dose
!( ) Rarely or Never 
2( ) 1-2 times a week 
3( ) 3-6 times a week 
4( ) Daily or more often
Vitamin C pills: 130-499 mg Dose
) Rarely or Never 
2( ) 1-2 times a week 
3( ) 3-6 times a week 
4( ) Daily or more often
83. 91. Other vitamin pills (Please specify)2 pills per dose
17 25 1 ( ) Rarely or Never 
2( ) 1-2 times a week 
3( ) 3-6 times a week 
4( ) Daily or more often





!( ) Rarely or Never
2( ) 1-2 times a week
3( ) 3-6 times a week
4( ) Daily or more often
93. How often do your daily activities 
seem extremely trying & stressful?
!( ) Every day 
2( ) Several times per week 
3( ) Few times per week 
4( ) Few times per month 
5( ) Rarely
6( ) Never
94. What are your smoking habits?
1{ ) Never smoked (Skip to #57).
2( ) Have smoked in the past but not 
now (Skip to #97).





86. Vitamin C pills: £30 mg-999 mg dose
1[ ) Rarely or Never 
2( ) 1-2 times a week 
3( ) 3-6 times a week 
4( ) Daily or more often
20
87. Vitamin C pills: 1300 mg or more
1[ ) Rarely or Never 
2( ) 1-2 times a week 
3( ) 3-6 times a week 
4( ) Daily or more often
Vitamin E pills: Under 100 units
J( ) Rarely 
2( ) 1-2 times a week 
3( ) 3-6 times a week 
4( ) Daily or more often
Vitamin E pills: 100 units or more
*( ) Rarely or Never 
2( ) 1-2 times a week 
3( ) 3-6 times a week 
\ ) Daily or more often
Vitamin A pills: Any Dose
3( ) Rarely or Never 
2( ) 1-2 times a week 
3( ) 3-6 times a week 
4( ) Daily or more often
3221
95. How many cigarettes do you smoke 
each day?
88.
22 or Never 3( ) None33
2( ! Less than 13( 1-4
4( ) J* pack (5-14)
5( ) 1 pack (15-24)
6( ) Us packs (25-34)
7( ) 2 packs (35-44)
6( ) 2h packs (45-54)
9( ) More than 2% packs (55 or more)
Do you smoke a pipe, cigar or 
cigarillo?
A ) Yes 
2( ) No
Do you use any other form of tobacco 
such as chewing tobacco or snuff?








Flease turn to the next page.Please go to the top of the next column.
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104. Which one of the following describes 
your present work situation?
98. What is your usual bedtime (check 
nearest category)
) 9 p.m. or earlier 
2( ) 10 p.m.
3( ) 11 p.m.
4( ) 12 p.m. or later
99. How many hours of sleep do you usually
get at night?
4336 *( ) Not employed on regular basis 
2( ) Homemaker with no other employment 
3( ) Retired
4( ) Temporarily out of work 
5( ) Work part time 
6( ) Work full time
7( ) Other (please specify):__________
i
37 ( ) Less than 6 hours 
2( ) 6 hours 
3( ) 7 hours 
4( ) 8 hours 
5( ) 9 hours or more
105.- What is your present occupation? (If 
retired or not presently employed, give 
your last occupation):
Job Title:
44 45100. How often do you suffer from insomnia?
l( ) Rarely or never 
2( ) Monthly 
3( ) Weekly 
4( ) Nightly
101. Do you currently have a planned 
exercise program?
M ) Yes
2( ) No -- What is your reason for not 
having a planned exercise pro­
gram?
x( ) Restricted due to illness 
2( ) Unplanned activities provide 
enough exercise 
3( ) Lack of time to exercise 
4( ) Lack of motivation 
5( ) Other (please specify)
Major duties or responsibilities:
38
106. Please mark the category which best 
describes your family's combined annual 
income:
3( ) Below $5,000 
2( ) $5,000 - $9,999 
3( ) $10,000 - $14,999 
4( ) $15,000 - $19,999 
s( ) $20,000 - $24,999 
6( ) $25,000 - $29,999 
7( ) $30,000 or more
What is your marital status?
1( ) Never married 
2( ) Married 
3( ) Widowed
4( ) Separated or divorced
What is the highest level of education 
you have completed?
:( ) 8th grade or less 
2( ) Some high school 
3( ) High School
4( ) Some college/trade or business 
5( ) College graduate 
6( ) Post graduate work
What is your race?
1[ ) American Indian 
2( ) Oriental 
3( ) Black
4( ) Spanish American 
5( ) White (Anglo)





102. In your LEISURE TIME, how many times 
per week do you usually engage in 
VIGOROUS activities such as hiking, 
or vigorous walking, running or jogg­
ing, bicycling, swimming, tennis,etc.?
( ) Seldom or never 
2( ) Less than 1 per week 
3( ) 1-2 times per week 
4( ) 3-4 times per week 
5( ) 5-6 times per week
How many minutes would you estimate you 
usually spend, per session, while 
engaged in vigorous activities? (Mark 
0-15 minutes for activities you do very 
seldom or never).
!( ) 0-15 minutes 
2( ) 16-30 minutes 
3( ) 31-45 minutes 
4( ) 46-60 minutes 
5( ) Over 60 minutes







Please turn to hack of page.
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-lo­
rn. (please check yes or no for each)Have you ever had any of the following:
Yes No
( )50 2( )1 Heart attack or coronary




2( ) Thyroid problems
2( ) Bronchitis
Pneumonia
2( ) Other lung or breathing problems (Please specify): 
2( ) Gout
H )51 2( )52 M ) 2( )5354 ( )1
H ) 2( )55 M )56 H )57
( )58 2( )1
( )59 160 H )61
*( ) 2( )62 Stomach or duodenal ulcer (gastric ulcer)
2( ) Any other health problems (please specify): 
2( ) High blood pressure
2( ) Sugar Diabetes
H )6364 H )65
H )66
Thank you for answering this questionnaire. Please quickly recheck 
the questionnaire to be sure no questions were left blank.











1- Have patient fill out the questionnaire.
2* Briefly check over questionnaire for questions unanswered.
3. Take diet history:
a. Note differences between weekends and weekdays intake.
b. Take down average quantity (portion size) of food intake.
c. Note foods in each category:
i. Beverages: milk, juices (sweetened or unsweetened), soup 
(canned or homemade), soft drinks, alcohols, 
coffee and tea (black or with sugar and cream).
ii. Protein: meat, fowl, fish, luncheon meats, egg, cheese, 
vegetarian protein.
iii. Fruit: fresh, frozen or canned (what kind of packina - 
heavy syrup, light syrup, water or its own juice).
iv. Vegetables: fresh, frozen or canned.
v. Bread: bread, crackers, noodles
vi. Fat: cooking fat, fried foods, chips, cream,
vii. Other: dessert - be specific about quantify and how often eaten. 
jam; jellies, syrups, candies, cookies, cakes, pies, 
ice cream, pudding, jello, sherbet,
d. Check snacking habits. Note time and quantity of food eaten.
4. 24 hour recall:
a. Ask patient to recall what was eaten during the previous day: 
breakfast, lunch and supper. Also include snacks.
b. Note down i) quantity (portion sizes) of food eaten.
ii) place eaten, 
iii) time eaten.
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o you think you don’t eat much sugar'
Here ire the approximate amounts of refined suaar (added sugar, in addition to the sugar naturally present) hidden in popular foods.
Appfoitmatc 




Sugar Content tn 
Teaspoonful of 
Granulated Sugar













Cakes and Cookies 
angel food 
apple sauce cake 
banana cake 
cheese cake 
choc, cake (plain) 
choc, cake (iced) 
coffee cake 































Canned Fruits and Juices 
canned apricots
31 (% oz)
1 (6 oz bottle or glass) 
1 (Y* oz glass)
1 (6 oz glass)
1 (8 oz glass)
1 (10 oz bottle)
1 (6 oz bottle or glass) 
1 (3 oz bottle)
1 cup












AY,1 (4 oz piece)1 (4 oz piece) 
1 (4 oz piece) 
1 (2 oz piece) 
1 (4 oz piece) 
l (4 oz piece) 
1 (4 oz piece) 
' 1 (4 oz piece) 
1
1 (4 oz piece) 
1 (2 oz piece) 
1 (4 oz piece) 
1 (4 oz piece) 





















4 4 halves and 1 T syrup 3V*
(over)
(XSP-Z276-I0M
INTERNATIONAL PHARMACEUTICAL CORPORATION Kanua CRy. MO MtU
Appranmatt 












■ Food Item Six* Portion Food Item Size Portion







fce cream cone 
ice cream soda 
ice cream sundae 
malted milk shake





































































1 (4 oz piece) 
Vi cup
4
2 halves and 1 T syrup 
Vi cup 3 Vi 73 V, 6
2 T 2Vi 5
Vi cup 2 4
2




71 (10 oz glass) 5
2





1 (4 oz piece)
Vi cup

















4 IT •3Vi1 1 oz •5
* actual sugar content
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cramilated sugar No. teaspoons ulatedFood Size Portion Size Portion sugargran
Cola drinks 1 (6 oz. bottle or 
glass) d¥t
1 Oi oz. glass)
6 oz.
1 (8 oz. glass) 5
1 (10 oz. bottle) 4Vt
1 (6 oz. bottle) 83A
1 (8 oz. bottle) 5
DAIRY PRODUCTS 
Ice cream 
Ice cream bar 
Ice cream cone 1
Ice cream soda 1
Ice cream 
sundae
Malted milk • 
shake
JELLIES & JAMS 





Strawberry jam 1 T
% pt. (3% oz.) 3% 






Sweet cider 1 cup
CAKES AND COOKIES.
Angel food 1 (4 oz. piece) 7
Apple sauce cake 1 (4 oz. piece)
Banana cake 1 (2 oz. piece)































Av. chocolate milk bar 
(ex. Hersey)
Chewing gum 








Peanut brittle 1 
CANNED FRUITS & JUICES 
Canned apricots 4 halv. dc 1 T syr. 3H 
Camied fruit 
juices sweetened Va cup 












1 T 11 (4 oz. piece)
1 (4 oz. piece) 
1 (4 oz. piece)
1 (4 oz. piece) 
1 (2 oz. piece) 
1 (4 oz. piece) 
1 (4 oz. piece) 
































Plum pudding *4 cup
Rice pudding *4 cup
Tapioca pudding *4 cup




4*4 *4 cup 
*4 cup 
*4 cup 
1 (4 oz. piece) 5
*4 cup 



































1 2 1*41 1*4
7 41 2
2 3 2*46 71 (4 oz. piece) 4*4 7






1 oz. square 
1
4 oz.


































ARA DIAGNOSTIC CRITERIA PAGEMONTH
**ENTRY DATA**




The patient must exhibit any 5 of the following 11 criteria. Please code as follows:
0 = absent, 1 = present, 8 = doubtful, 9 = not investigated
____ Morning stiffness.
____ Pain on motion or tenderness in at least one joint (observed by a physician).
____ Swelling (soft tissue or fluid, not bony overgrowth alone) in at least one joint
(observed by a physician).
____ Swelling (observed by physician) of at least one other joint (any interval free
of joint symptoms between the two joint involvements may not be more than 
3 months).
_____Symmetrical joint swelling (observed by physician) with simultaneous involvement
on both sides of body (bilateral involvement of midphalangeal, metacarpophalangeal 
or metatarsophalangeal joints is acceptable without absolute symmetry). Terminal 
phalangeal joint involvement will not satisfy this criterion.
____ Subcutaneous nodules (observed by a physician).
____ X-ray changes typical of RA (must include at least bony decalcification localized
to or greatest around the involved joints, not just degenerative changes). 
Degenerative changes do not exclude RA.
____  Positive Agglutination test — demonstration of rheumatoid factor by any method
s which, in 2 labs, has been positive in not over 5% of normal controls.
____ Poor mucin precipitate from synovial fluid.




NAME PT. NO. Date__ /__ /__
m d yr
ARA EXCLUSIONS
0 = absent, 1 = present, 8 = doubtful, 9 = not investigatedPLEASE CODE:
The typical rash of disseminated lupus erythematosus.
High concentration of lupus erythematosus cells (four or more in two smears 
prepared from heparinized blood incubated not over two hours).
Histological evidence of periarteritis nodosa.
Dermatomyositis.
Definite scleroderma.
_A clinical picture characteristic of rheumatic fever (an elevated antistrep­
tolysin titer will not rule out the diagnosis of rheumatoid arthritis).
_A clinical picture characteristic of gouty arthritis. (An elevation of uric 
acid in the blood does not necessarily exclude rheumatoid arthritis).
_ Tophi.
_A clinical picture characteristic of acute infectious arthritis.
_ Tubercle bacilli in the joints or histological evidence of joint tuberculosis.
_A clinical picture characteristic of Reiter's syndrome.
_A clinical picture characteristic of the shoulder-hand syndrome.
_A clinical picture characteristic of hypertrophic pulmonary osteoarthropathy.
__ A clinical picture characteristic of neuroarthropathy.
_ Homogentistic acid in the urine detectable grossly with alkalinfzation.
_ Histological evidence of sarcoid or positive Kveim Test.
_ Multiple myeloma as evidenced by marked increase in plasma cells in the bone 
marrow, or Bence-Jones protein in the urine.
_ Characteristic skin lesions of erythema nodosum.





NAME Date__ /__ /__
m d yr
Pt. No.
THESE CONDITIONS DEFINITELY EXCLUDE FROM THE TRIAL:
Please code: 0 = absent, 1 = present, S = doubtful, 9 = not investigated
Arthritis before the age of 16
Arthritis associated with ulcerative colitis
Ankylosing spondylitis
Arthritis associated with psoriasis
Pregnancy or the intention to become pregnant, or nursing mothers 
Severe infection
Hypertension (diastolic pressure >-100)
Major surgery in the past six weeks
Anemia other than anemia associated with rheumatoid arthritis
Diabetes not controlled by diet alone
-Known liver disease
Active peptic disease
Abnormal urine sediment or creatinine above 1.5 mgm% 
Active tuberculosis
Doubtfulness of the patient's dependability in attendance at scheduled times 
or likelihood of completing the trial
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MONTH PAGECRITERIA FOR ADMISSION
**ENTRY DATA**
NAME:





List all drugs taken for RA. in the past six months:
Drug Name Dose Date Discontinued
MAIN STABLE DOSE MEDICATIONS:
*[ ] Anti-inflammatory drug 
![ ] Penicillamine 





IF PATIENT IS SUITABLE FOR INCLUSION IN THE TRIAL, RECORD THE FOLLOWING:
Sex: 1 = female 2 = male 
Birth Date
16
17-^22 ■ I i I i
Mo. Da. Yr.
__ __ Age at onset of RA - Not age today
Duration of RA - Years
23-24
25-26
__ __ Body Weight (pounds)
__ __Height (inches) — not in feet and inches
__ARA anatomic stage (enter as 1-4; see p. 3 of Observer's Guide)
__ __Nodules, number










0 4 Ft. No.1-5 NAME:
6-11 ____ !____ /. Date
____ Follow-up Month No.12-13
HEMATOLOGY
__________ Total white blood count (W3C cells/cu. mm.)
DIFFERENTIAL COUNT — 100 Cells Counted
______  Neutrophils %
______  Lymphocytes %
______  Monocytes %
______  Eosinophils %
______Basophils %
______  Bands %
_______.___Hemoglobin gms %
_____.___Hematocrit %




















1:5160-6351 Rheumatoid Factor (check one) 
Negative 
] 1:40 
2[ ] 1:80 
5[ ] 1:160 
'[ ] 1:320 
5[ ] 1:640 
‘[ ] 1:1280 
’[ ] 1:2560 






















0 3 Pt. No.l-T NAME:
_ _/____ /_ _
Mo. Da. Yr.
Date6-n
Follow-up Month No. 
MORNING STIFFNESS - PAST WEEK
12-13
1li* [ ] No stiffness past week
2[ ] Stiffness (please indicate usual time according to 24-hour clock
TIKE (Hours:Minutes, 24-hour clock)
Past Week
______ Patient Awakened
______. First aware of stiffness
______  First aware of fatigue











GRIP STRENGTH (in mn hg)
Alternate tests between Right and Left Hand
RIGHT HAND
_________  1st Try
_________  2nd Try





______  1st Try






sec. First 25 feet 




[ ] Yes 
2[ ] No
i If Yes, specify67
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MONTH JOINT EXAMINATION 
♦♦ASSESSMENT DATA**
Page
0 3 Pt. No. NAME;
Date
m d yr 
THE JOINT EXAM
T = Tender and/or Pain 
Score on a scale of 0 to 4:
0 = None 1 = ? 2 = minimal 3 = moderate 4 = severe
RIGHT
T S T S
S = Swelling
LEFT RIGHT





















MCP I III22-25 28-31
II IV26-29 32-35
III V30-33 36-39
. IV TOES I34-3/ 40-43
V Prox II38-41 44-47
PIP I and III42-45 48-51
II Dist IV46-49 52-55
III VIPs50-53 56-59




DIP II Hot Joints:62-65
III Number66-69 62-63
IV70-73






MONTH ♦♦ASSESSMENT DATA** PAGE





1 Complete: Ability to carry on all usual duties without handicaps.
2 Adequate for normal activities: Despite handicap of discomfort or
limited motion at one or more joints.
Only to little or none of duties of usual occupation or
ll ]67
2[ ]
3C ] 3 Limited:
self care.
4 Incapacitated, largely or wholly: Bedridden or confined to wheelchair:
little or no self care.
-[ ]
ASSESSMENT OF PATIENT'S CONDITION 
(Clinical Observer's must be recorded first!) 
PAST MONTH 
OBSERVER 
[ ] very good 
2[ ] good 
3[ ] fair 
"C ] poor.
5[ ] very poor
i68
PATIENT 
*[ ] very good 
2[ ] good 
3[ ] fair 
"C ] poor 
5[ ] very poor
PHYSICIAN OBSERVER CODE 
*[ ] E. H. Krick, M.D.
2[ ] Steen E. Mortcnsen, M.D. 
3[ 3 Elliot Kopp, M.D.






MONTH SIDE Ef'FCCTS Page
♦♦ASSESSMENT DATA**
NAME: Pt. No. Date__ /__ /_
m cl yr
UNDESIRABLE SIGNS AND SYMPTOMS since last assessment
For every side effect, please describe fully, including Date of Onset, 




* 1 = Mild
2 = Moderate
3 = Severe
+ A = Probably drug related 
B = Possibly drug related 
C = Probably not-drug related
. CURRENT MEDICATION LIST(include Gold, Penicillamine, Prednisone)
________ Cbmpleted byDate







FRUIT CHOICE/SUBSTITUTE VEGETABLE CHOICE/SUBSTITUTE
Calorlcs-AS; Proteln=0.5 gm; no fat Calorlca=25; Protein=l gm; no fat
TOTAL PATTERN FOR niE DAY
Apple
Amount of Servings Applesauce
1 (2"diam) v 
% cup




’;(6" diam) or 







Kind of Food 3 med, spears 
% cup
1 sm. stalk 





% cup diced 
\ oup
Greens (mustard, spinach, turnip, 
kale, beet, etc.)
















































































































MOTE; All fruits and juices should be fresh, canned or frozen and NO SUGAR ADDED.
Calories=45; no protein; fat=5 gm.
Avocado, 3V' x 4"
Margarine 
Mayonnaise 








1 tsp. LnroNO butter, cream or lard
i
MILK CHOICE/SUDSTITUTE BREAD CHOICE/SUBSTITUTELOW PROTEIN, LOW SUGAR, LOW FAT
Calories=80; Protein=8 gm; no fat Calories=70; Protein=2 gtn; no fatDally Meal Pattern




Yogurt, plain low fat 1 cup
Bread















%Milk 1 <2" diam)




Protein Calories=65; Protein=7 gm; Fat=5 gm. h
lFruit Egg (3 times a week)
Cheese: skimmed morzerella, hoop, 
farmer, low-fat (Cheezola,etc.)
1 ounce




(subtract 2 fat Choice)
1 %















Vegetables Poultry: % leg or 1 slice breast 
or thigh
Salmon or tuna: flaked, packed 





















1 ounceFat 3 medium 
1 ounce
Dinner:
* * ** *
Protein AVOID beef, pork, and lamb.
TRIM off all extra fat before 
cooking.
AVOID organ meats, luncheon meats, 
they are high in cholesterol.
EGG yolks are the highest single 
source of cholesterol..Limit 
to three whole eggs per week.
May use egg white/egg substitute 
within protein allowance.
AVOID nuts and seeds, they are 
high in protein and fat.
Bread 1 ear or 1/3 cup 
\ cup














QUANTITATIVE DETERMINATION OF B LYMPHOCYTES AND T LYMPHOCYTES 
Using S-DZS^-Iodo 2' Deoxyuridine Uptake
(Modification of procedure from: Pellegrino, M.A., Ferrone, S., Pellegrino, A., 
and Reisfeld, R.A.: A Rapid Microtechnique for in Vitro Stimulation of Human 
Lymphocytes by Phytohemagglutinin. Clin. Immunol. Immunopath. 2_: 67-73, 1973).
PURPOSE:
This test measures the in vitro response of lymphocytes to the nonspecific mitogens 
phytohemagglutinin (PHA), pokeweed (PWM), and Concanavalin A. Lymphocyte response 
is evaluated by the incorporation of radiolabeled lUdR by cells cultured in the 
presence of varying doses of PHA, PWM, and Con A. B (bone marrow derived) lympho­
cytes are recognized by direct immunofluorescent staining of their cell surfaces.
T (thymus derived) lymphocytes have the capacity to form rosettes with sheep red 
blood cells.
TYPE OF SPECIMEN REQUIRED:
10 ml of heparinized blood drawn 4 hours from the patient.
TIME FOR ASSAY COMPLETION:




Multiple Automated Sample Harvester (MASH) - 
Searle Microbiological Associates 
Incubator, Humidified C0?
Centrifuge, PR-6000
Coulter Counter or WBC Counting Chambers 
RPMI - 1640 + Hepes Buffer 
RPMI - 1640 (IX)
Fetal Calf Serum 
Penicillin-Streptomycin Solution 
10,000 U Pen - 10,000 meg Strep 
L-Glutamine 200 mM 
Ficoll-Paque 
5-IodoT2' Deoxyuridine 
5-(1251) lodo 2' Deoxyuridine 10 ug/uCi 
500 uCi - Amersham Searle Corp.
Microtest II Plate 
Microtest II Lid 
Tubes - 15 ml - Conical 













Falcon #2095 or Corning 25310 









Vacutainer, Green Top, Heparinized Tubes 
Nalgene Filters 0.45 micron 
Trypan Blue Stain 0.4%
Oxford Pipettor Dispensing 2 ul & 5 ul 
Oxford Pipettor Dispensing 200 ul
Miles-Yeda Lt. 79-003 
GIBCO #536





120 ml heat inactivated FCS 
460 ml RPMI 1640 
400 ml RPMI + 25 mM Hepes 
10 ml Pen-Strep solution 
10 ml L-Glutamine 
Filter in sterile Nalgene units.
Freeze in sterile 50 ml conical tubes. 
Final concentrations in the media are: 
12% FCS 
10 mM Hepes 
100 U/ml Pen 







Add 5.0 ml RPMI to one bottle
Aliquot 0.45 ml per sterile 5 ml-capped tube and freeze at -20°C. 
Con A Stock
Place 1 mg in capped tubes and store -20°C.
For use add 1.0 ml RPMI.
PWM Stock
Add 10 ml RPMI to one bottle.
Aliquot 0.5 ml per sterile 5 ml capped tube and store at -20°C. 








Grand Island Biological Co. #410IV. Pucks Saline G (IX)
V. 1% BSA-Pucks washing solution
20 gm BSA (fraction V) Miles Lab.
2000 ml Pucks Saline 
Mix:
pH 7.35 - 7.40
Filter in disposable units, Nalgene filters 0.45 micron membrane. 
Aliquot into sterile 50 ml containers and freeze.
VI. Stock sodium azide 0.2M 
1.3 gm Na Azide
100 ml Phosphate Buffered Saline 
Store in refrigerator 1 yr.
Working sodium azide
a. For washing cells, add 2.5 ml to 47.5 ml 1% BSA-Pucks
VII. Immunofluorescent Reagents
F/P ratio 4-5 ug/mg. 0.5 mg protein/ml
a. Polyvalent - Meloy C520
b. F(ab) 2' IgM and IgD (stable surface immunoglobulin)
c. Kappa - Meloy C506
d. Lambda - Meloy C507
e. Alpha F(ab) 2' - Meloy C502
f. Delta F(ab) 2' - Meloy C504
g. Gamma F(ab) 2' - Meloy C501
h. Mu F(ab) 2' - Meloy C503
i. Epislon - Meloy C505 
Aliquot and store in freezer at -70°C.
VIII. Sephadex Buffer
233.9 gm NaCl 
48.4 gm Tris
14.8 gm EDTA (Disodium) 714 
Bring mixture to 3L with distilled water, 
with cone. HC1. Bring final volume to 4L. 
for use dilute 1:10 with distilled water.
Carefully buffer to pH 8.0 




IX. Stock Acrydine Orange 4.1 gm%.
4.1 gm Acrydine Orange 
100 ml Distilled Water 
Store in refrigerator 
Working Acrydine Orange:
Iimiediately before use, predilute the well-mixed stock of A.O. by 
adding 50 ul to 20 ml water. This concentration is stable for only 
a day.
Working A.O.
Add 300 ul of prediluted stock to 75 ml Sephadex Buffer.
Stable for 50 slides.
X. Absolute Methanol 
XI. Tris Buffer
2.0594 gm Tris 
180 ml water 
pH 7.65 with cone. HC1 
Store in refrigerator
XII. Fresh supply of Sheep RBC's in A1severs solution. (Obtain from Immuno 
Chemistry.)
XIII. Neuraminidase
Grand Island Biological Co. #70500 
XIV. Mounting Media 
5 gm Tris 
50 ml Water 
pH 8.8 with cone. HC1 
Place buffer in 500 ml volumetric flask 
qs with glycerol
XV. 0.1% stock cold. 5-Iodo 2' Deoxyuridine (ILIdR) 1 ug/1 ul
a. Add 50 mg lUdR to 50 ml media.
b. Warm gently at 37°C until all lUdR is in solution.
c. Depending on the batch of Isotope, it is sometimes necessary to 
have a 0.2% stock.
XVI. 10 ^ M 5-Iodo 2' Deoxyuridine in Saline, 




XVII. 0.1% Trypan Blue for viabilities 
Dilute 0.4% 1:4 with PBS.a.
XVIII. Wash Solution
9.25 g FTA Hemagglutination Buffer 
1 liter water
Dissolve Buffer in water. Autoclave 






Preparation of sheep RBC's and neuraminidase treatment (Sheep cells must 
be fresh).
1.
a. Obtain about 2 ml SRBC.
b. Wash three times in Pucks Saline.
c. Prepare a 5% suspension.
d. To 4 ml of the 5% suspended cells add 200 ul neuraminidase.
e. Incubate cells and neuraminidase at 37°C for 30 min.
f. At the end of this time, wash twice more in Pucks Saline.
NOTE: After the cells have been treated, they become fragile.
Care should be taken so they remain in the cold until 
ready for use.
To prepare a final 2% suspension of nontreated and treated SRBC, place 
0.1 ml of packed SRBC in 5.0 ml Pucks Saline. There will be approximately 
100 x 10° cell s/ml.
*This 2% suspension is good for one week but should be washed once before 
use on subsequent days.
PROCEDURE (STERILE TECHNIQUE THROUGHOUT):
g-
1. Lymphocyte separation
a. Obtain a blood specimen from each patient and also from a control. A 
10 ml - draw green top vacutainer tube and a 4 ml - draw lavender top 
tube is needed from each person.
b. Dilute 1 volume heparinized blood (green top tube) with 1 volume RPMI 1640.
c. Aliquot 3 ml of the Ficoll-Paque into 3 sterile 15 ml conical tubes.
d. Layer 5 ml of diluted blood over the Ficoll-Paque solution with a 
sterile pi pet taking care not to disturb the interface.
e. Centrifuge 1500 RPM (PR-6) for 40 minutes at room temperature (400 g's 
at the interface).
f. Aspirate the white layer of cells at the interface with a sterile pasteur 
pipet and half the amount of the gradient above the RBC pack.
Pool the cells into a 50 ml conical plastic tube and fill with wash solution 
for the first wash.
h. Spin for 15 minutes at 1500 RPM at room temperature.
i. Pour off supernate leaving approximately 5-7 ml and wash the pellet 
twice more with 20 ml wash solution. For the second and third washes 
spin for 10 min. at 1500 RPM.
j. After the last centrifugation, aspirate with a sterile pipet and 





k. Do a WBC count (and viability) on the cells.
A viability test is done by mixing one drop trypan blue 
with a drop of cells. Those cells which take up the dye 
are dead. Viability is expressed as a percent.
2. Microtiter Place Preparation
Washed lymphocytes must be adjusted to 0.5 x 10^ cells per ml in 
cell culture media.
a.
b. Place 200 ul of the adjusted cell suspension into wells in a 
sterile flat bottom microtiter plate. Each well has 100,000 
cells. Save 3 to 5 ml's of suspension for B and T cell 
quantitation.




PHA-P 1:2 1:5 1:10 1:50 1:100Neat
PWM 1:10 1:25 1:50Neat 1:100 1:200
Con A 1:2.5 1:5 1:10Neat 1:125 1:50
With a 5 uL dispensing Oxford add, in triplicate, each dilution.
Be sure to set up a control with no mitogen to measure any non­
specific response.
Mitogens are good for one month in the diluted forms if thawed 





a. Incubate cultures 3 days (72 hrs.) at 37°C and 5% COp in a 
humidified incubator.
b. If mitogens are placed in the wells at 4:00 p.m. Friday, by 4:00 p.m. 
Monday the cultures are ready to be pulsed.
4. B-Cell and T-Cell Quantitation
a. Pipet 1 ml of 0.5 x 10^/ml cell suspension into each of 3 small 
Fisher centrifuge tubes. 2 of these tubes are for E-rosettes and 





1. Spin one of the Fisher tubes at 1200 g's for T minute.
2. Aspirate supernate leaving approximately 50 ul, add 1 ml of 
Pucks saline.
3. Centrifuge at 1200 g's for 1 minute. Aspirate off supernate leaving 
approximately 20 ul above cell button.
4. Add 50 ul of Polyvalent antisera. (Dilute antisera 1:3 before use)
5. Mix and incubate at 4°C for 30 minutes.
6. Wash 3 times with Pucks saline and centrifuge at 1200 g's for 1 min.
7. At end of washes, aspirate all but about 20 ul.
8. Resuspend and make 3-4 good blood smears, using all the cells.*
Air dry thoroughly, about 25 min. Store slides in refrigerator.
*Make smears by placing drop of suspension on one slide, place another 
slide on top of the drop and slide slides apart.
9.
c. E-Rosetting
1. Centrifuge the remaining 2 Fisher tubes at 1200 g's for 1 min. 
Aspirate supernate leaving approximately 50 ul.
3. Add 1 ml Pucks saline to each tube, mix.
4. Centrifuge at 1200 g's for 1 min.
Aspirate supernate, leaving approximately 50 ul.
6. Add 0.2 ml of untreated SRBC's to one tube and 0.2 ml of
neuraminidase treated SRBC to the other tube. (This produces 
a 40-50:1 ratio of SRBC's to lymphs)
Add eanough Pucks saline to make final volume in Fisher tubes 
about 1 ml.
8. Mix well and incubate at 37°C for 5 min.
9. Centrifuge at 400 g's for 5 min.
10. Incubate tubes in the refrigerator at 4°C or on ice for a minimum 
of 4 hours before reading. Overnite incubation works well.
d. Counting E-rosettes
Dilute stock scrydine-orange 1:500.
Aspirate supernate from Fisher tubes leaving 50 ul above cell button. 
Add an equal volume of diluted acrydine orange. (1 drop)
Carefully and gently aspirate all the cell button and acrydine 
orange into the barrel of a 9" pasteur pipet. Resuspend gently 
inside the pipet and place a small drop on a slide and then 
coverslip.
Let the cells settle about 1 minute, then count 200 lymphocytes 
differentiating rosettes from non-rosette lymphocytes.
Rosettes are lymphocytes with three or more sheep RBC's adhering to 
their surface. Use both the fluorescent lamp and regular light 













e. Counterstaining slides with Acrydine Orange. For B-Cells.
1. Stain one slide for each antisera type and keep the extras in 
microscope boxes in the refrigerator.
2. Fix in absolute methanol 4-5 min. Dry.
3. Wash once in Sephadex buffer 1-2 minutes.
4. Stain 6 minutes in freshly prepared working acrydine orange.
5. Wash once for 6 minutes or more in Sephadex buffer.
6. Air dry and mount in standard buffered glycerol mounting media.
Counting Surface Immunoglobulin Positive Lymphocytes.
1. Using the ultra-violet microscope, FITC exciter filter and 500 
barrier, a minimum of 300 lymphocytes per slide should be counted 
separating cells into surface Ig positive or negative.
The percentage of positives is recorded as the number of B-lymphs.
3. The Acrydine Orange counterstain will stain all nuclear material
smoothly green at the dilution used. The occasional neutrophile will 
be easily identified and ignored. Ig positive cells appear speckled 
and patched with fluorescein.
2.
5. Pulsing
a. At thejend of 3 days each culture well receives 0.5 uCi/ug of 
5-(125j Iodo-2' Deoxyuridine from a 10 ul dispensing Stepper pipettor.
b. The cultures are pulsed at 4:00 p.m. on the third day and returned 
to the incubator for an additional 18 hrs.
6. Harvesting
At the end of 18 hours or 10:00 a.m. next day the cells are harvested 
with the use of the MASH unit. n




Wells are aspirated and filled a total of 4 times.
Filter paper strips are dried briefly at 37°C (dry oven) and the 
filter disks are pulled out with forceps and placed in properly 
labeled test tubes for the gamma counter.





a. The 3 cpm for each point are averaged and a stimulation index is 




cpm (PHA) responding cells
cpm of control cells (no PHA)
c. Graph results on semi log paper according to the S.I. and dilution 
with its dosage of the mitogen.
b. The stimulation index is:
CALCULATIONS:
For "E" Rosettes
Determine mean and SD of positive cells.
For B-Lymphocytes
Determine % of positive cells
in 64/300, 63/300 = 127/600 x 100 = 21% positive
NORMALS:
37°C stable B-Lymph 
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ADJUSTMENT OF DEOXYURIDINE - EXAMPLE
II. 125 lododeoxyuridine - Information on Bottle
IM 355Order Number 
Batch Number 




II. 1.06 mCi/ml _ 1.06mCi/ml _
5000 mCi
III. (.000212 mg/ml) (.47 ml) = .0000996 mg = .0996 ug
IV. We want to adjust isotope to 1 u Ci/1 ug.








We have 500 uCi. We also have 
We should add 499.9 ug of cold IUDR.500.0
0.1
499.9 ug
The 0.9% cold IUDR is at a concentration of 1 ug/ul.
(essentially 0.5 ml) of cold IUDR to the isotope bottle.
IUDR/500 ug IUDR = 1 u CI/1 ug in 0.5 + 0.47 ml RPMI.
V. 500 uCi/2000 ul = 0.25 u Ci/ul. We want to add 0.5 uCi to each well. We pulse 
by adding 10 ul isotope adjusted to 500 uCi/2000 ul.
So we should add 0.499 ml 
This gives us 500 uCi
